Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenoabnormal ophthalmic nerve morphology

SEMA3A MEGF8

1.84e-054252MP:0009798
DomainEGF_extracell

LRP2 ADAM11 ADAM12

1.46e-0460323IPR013111
DomainEGF_2

LRP2 ADAM11 ADAM12

1.46e-0460323PF07974
DomainTIL_dom

LRP2 MUC2

2.55e-0414322IPR002919
DomainDisintegrin_CS

ADAM11 ADAM12

3.36e-0416322IPR018358
DomainADAM_CR

ADAM11 ADAM12

4.28e-0418322PF08516
Domain-

ADAM11 ADAM12

5.30e-04203224.10.70.10
DomainDisintegrin

ADAM11 ADAM12

5.85e-0421322PF00200
DomainDISIN

ADAM11 ADAM12

5.85e-0421322SM00050
DomainEGF_3

LRP2 ADAM11 MEGF8 ADAM12

6.66e-04235324PS50026
DomainEGF-like_dom

LRP2 ADAM11 MEGF8 ADAM12

8.27e-04249324IPR000742
DomainEGF_1

LRP2 ADAM11 MEGF8 ADAM12

9.03e-04255324PS00022
DomainACR

ADAM11 ADAM12

9.72e-0427322SM00608
DomainADAM_Cys-rich

ADAM11 ADAM12

9.72e-0427322IPR006586
DomainEGF-like_CS

LRP2 ADAM11 MEGF8 ADAM12

9.85e-04261324IPR013032
DomainEGF_2

LRP2 ADAM11 MEGF8 ADAM12

1.04e-03265324PS01186
DomainPeptidase_M12B_N

ADAM11 ADAM12

2.03e-0339322IPR002870
DomainPep_M12B_propep

ADAM11 ADAM12

2.03e-0339322PF01562
DomainDISINTEGRIN_1

ADAM11 ADAM12

2.13e-0340322PS00427
DomainReprolysin

ADAM11 ADAM12

2.13e-0340322PF01421
DomainADAM_MEPRO

ADAM11 ADAM12

2.13e-0340322PS50215
DomainDISINTEGRIN_2

ADAM11 ADAM12

2.13e-0340322PS50214
DomainPeptidase_M12B

ADAM11 ADAM12

2.13e-0340322IPR001590
DomainDisintegrin_dom

ADAM11 ADAM12

2.24e-0341322IPR001762
DomainPSI

SEMA3A MEGF8

2.57e-0344322IPR016201
DomainTPR_REGION

TMTC2 DELE1 TTC28

2.78e-03165323PS50293
DomainTPR

TMTC2 DELE1 TTC28

2.78e-03165323PS50005
DomainPSI

SEMA3A MEGF8

2.81e-0346322SM00423
DomainTPR_2

TMTC2 TTC28

3.31e-0350322PF07719
DomainTPR_2

TMTC2 TTC28

3.31e-0350322IPR013105
DomainTPR_8

TMTC2 TTC28

3.71e-0353322PF13181
Domain-

TMTC2 DELE1 TTC28

5.25e-032073231.25.40.10
DomainTPR-like_helical_dom

TMTC2 DELE1 TTC28

7.28e-03233323IPR011990
DomainEGF

LRP2 ADAM11 MEGF8

7.45e-03235323SM00181
DomainMetalloPept_cat_dom

ADAM11 ADAM12

8.47e-0381322IPR024079
Domain-

ADAM11 ADAM12

8.47e-03813223.40.390.10
DomainEGF_CA

LRP2 MEGF8

9.50e-0386322PF07645
Pubmed

Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.

TPSAB1 TPSB2

8.20e-0723229521329
Pubmed

The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.

TPSAB1 TPSB2

8.20e-07232210500112
Pubmed

Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.

TPSAB1 TPSB2

8.20e-0723222187193
Pubmed

Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.

TPSAB1 TPSB2

8.20e-0723228434231
Pubmed

Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.

TPSAB1 TPSB2

8.20e-07232215567416
Pubmed

Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.

TPSAB1 TPSB2

8.20e-07232210391906
Pubmed

The human mast cell tryptase tetramer: a fascinating riddle solved by structure.

TPSAB1 TPSB2

8.20e-07232210708850
Pubmed

Cloning and characterization of a second complementary DNA for human tryptase.

TPSAB1 TPSB2

8.20e-0723222203827
Pubmed

Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.

TPSAB1 TPSB2

8.20e-07232217449330
Pubmed

Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.

TPSAB1 TPSB2

8.20e-07232231337736
Pubmed

Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.

TPSAB1 TPSB2

8.20e-07232210898108
Pubmed

Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.

TPSAB1 TPSB2

2.46e-0633229920877
Pubmed

A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal.

SEMA3A MEGF8

2.46e-06332220410128
Pubmed

Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells.

ADAM11 ADAM12

2.46e-0633229461614
Pubmed

Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.

TPSAB1 TPSB2

2.46e-06332219748655
Pubmed

Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone collapse.

SEMA3A MICAL1

4.92e-06432221521879
Pubmed

Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.

TPSAB1 TPSB2

8.19e-06532210843716
Pubmed

New developments in the genetics and activation of mast cell proteases.

TPSAB1 TPSB2

1.23e-05632212217407
Pubmed

A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.

TPSAB1 ZCCHC7 MEGF8 MUC2

3.70e-0520532412040188
Pubmed

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.

SEMA3A ANGPTL2 ADAM12 CFHR4

7.76e-0524832424006456
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

SEMA3A TMTC2 MEGF8 ADAM12 DDX1 CEMIP2 GNPTAB

9.08e-05120132735696571
Pubmed

Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.

LRP2 GALNT5

2.24e-042432231740596
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

LRP2 TPSAB1 PIK3C2B TPSB2

2.29e-0432932417474147
Pubmed

Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis.

TPSAB1 PLA2G2F

2.84e-042732223624557
Pubmed

The core SWI/SNF catalytic subunit Brg1 regulates nephron progenitor cell proliferation and differentiation.

LRP2 PBRM1

4.79e-043532232504627
InteractionDEFB109B interactions

ADAM11 MEGF8 CEMIP2

2.95e-0538323int:DEFB109B
InteractionFBXO2 interactions

LRP2 GALNT5 MEGF8 CEMIP2 GNPTAB AMOTL1

4.01e-05411326int:FBXO2
Cytoband1q32

PIK3C2B CFHR4

5.42e-04493221q32
GeneFamilyADAM metallopeptidase domain containing|CD molecules

ADAM11 ADAM12

4.43e-042721247
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

TMTC2 TTC28

7.78e-03115212769
CoexpressionAtlasEctoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05

SEMA3A LRP2 MICAL1 TMTC2 ADAM11 ANGPTL2 RWDD2A TTC28 CEMIP2 DYRK1B

3.77e-0514663210PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlasgeo_heart_top-relative-expression-ranked_500_k-means-cluster#5

TPSAB1 TPSB2

6.13e-058322geo_heart_500_K5
CoexpressionAtlasEctoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05

LRP2 MICAL1 TMTC2 ADAM11 TTC28 PIK3C2B CEMIP2 DYRK1B

7.12e-05967328PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05
CoexpressionAtlasEctoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05

LRP2 MICAL1 ADAM11 ANGPTL2 TTC28 PIK3C2B CEMIP2 DYRK1B

1.49e-041075328PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PIK3C2B DENND3 CEMIP2 AMOTL1

2.53e-07193325826b8dd801298b3e0cd76232feae5a14026b8806
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PIK3C2B DENND3 CEMIP2 AMOTL1

2.53e-0719332587d3a577d37fb0cb4b6313c596310de452bc3872
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PIK3C2B DENND3 CEMIP2 AMOTL1

2.53e-07193325d485634c564b268e344b6a2863c26f6adaec9e38
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZCCHC7 PIK3C2B NIBAN3 MACROD2

3.38e-06144324b2a9f3b5dd46d27689467f4a5fd717cd5827821f
ToppCellChildren_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 PIK3C2B TPSB2

4.07e-06151324bbf735c6433c3fc2feedb24ed6f48c51d545fb60
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TPSAB1 ADAM12 TPSB2 GNPTAB

5.65e-061643242c48c6e4eeee845f0563982d0bfa2a176ca5ef61
ToppCell3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 PIK3C2B NIBAN3 TPSB2

6.22e-0616832455f328353119cbdc521c782ebb8d163876f4186d
ToppCellCOVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type

TPSAB1 ADAM12 TPSB2 GNPTAB

6.51e-06170324e90f18e5462381b38e918442b38b1c8105291908
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PLA2G2F ACP5 CEMIP2 MACROD2

6.98e-0617332423248019c819f6e38337dcc4edb763ef1992e89e
ToppCellMild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ZCCHC7 TTC28 NIBAN3 MACROD2

6.98e-06173324694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PLA2G2F ACP5 CEMIP2 MACROD2

6.98e-06173324f135cc9dcf34f33ced3210171ab40ae6d77cfae0
ToppCellCOVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type

TPSAB1 ADAM12 TPSB2 GNPTAB

7.47e-06176324473c45a381ca109207d66ed1635668b391ea0e1f
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TPSAB1 ADAM12 TPSB2 GNPTAB

7.81e-06178324c6704fcd21a9d2fe45679a1d998f04213b3bf224
ToppCellThalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.C1ql2_(Anterodorsal_thalamic_nucleus)|Thalamus / BrainAtlas - Mouse McCarroll V32

PLA2G2F MUC2 PADI1

7.91e-06543238a8abf565ea657bf16059c51a63534ede3d7ac12
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PIK3C2B DENND3 AMOTL1

8.16e-06180324423454e3390080ae03bb3cbb267255ebfe4df080
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 PIK3C2B DENND3 AMOTL1

8.16e-06180324dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DCAF17 ZCCHC7 PIK3C2B NIBAN3

8.34e-0618132475035a3211e524bb659b82e6979f7d3a3121ae70
ToppCell(4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

ZCCHC7 NIBAN3 CEMIP2 MACROD2

8.71e-0618332421b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TPSAB1 ADAM12 TPSB2 GNPTAB

9.09e-061853243fafb1d36c5f98a29d20a5ce5192c83d6f603514
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.29e-06186324f690e26b2ed024bd8ede494b8e9a00976fdc9734
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.49e-06187324bdcef4f3e093c3646b639a189bbe93d6f4c40f3c
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.49e-0618732409348f1e8bbbca8dca885461937b9b1dd248b034
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.49e-061873240f7a42c55997e34a0d20e492e16b03e91e965335
ToppCellControl-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type

ZCCHC7 NIBAN3 ACP5 MACROD2

9.49e-0618732490c9b1a51539838323325f563be4adf5fdf1b38f
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZCCHC7 PIK3C2B NIBAN3 MACROD2

9.49e-06187324c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.49e-06187324064730fa72f8637c3db3fc34d2e363d2b9a38f1d
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAM12 DENND3 CEMIP2 AMOTL1

9.69e-061883240aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZCCHC7 NIBAN3 CEMIP2 MACROD2

9.69e-06188324d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PLA2G2F ACP5 CEMIP2 MACROD2

9.69e-06188324ef05d2fb17fd427d46d454e67073e0e1b45bb24c
ToppCell3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.89e-061893241893765b1e3b306f1e133101c28403070a70c3c8
ToppCell5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.89e-06189324f01158bb15df3117fae1271bf8cf8c2501422671
ToppCell3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.89e-0618932496566f84c796d5b2e31f64090555f2b258f0c9f2
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PLA2G2F ACP5 CEMIP2 MACROD2

9.89e-06189324ebaf722738c71d5f33f72341f801c6880f4aee14
ToppCell3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.89e-0618932419b639bc6b35fe1d1079f60c8138aa946a95f3bf
ToppCell3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

9.89e-06189324b59cc66f7bb9b72895b775fbcf1ec1dc08610969
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAM12 DENND3 CEMIP2 AMOTL1

1.01e-0519032425525fee1da8a808034d9c916159fd0b6b26bce8
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAM12 DENND3 CEMIP2 AMOTL1

1.01e-05190324a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCellBLOOD--(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ZCCHC7 NIBAN3 CEMIP2 MACROD2

1.01e-05190324bde288cea27bbdc3ca05737a00fe30a0103a4c74
ToppCellMild/Remission-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ZCCHC7 NIBAN3 CEMIP2 MACROD2

1.03e-05191324ebb165096de301ba663703d1662d9413ea317867
ToppCellcellseq-Immune-Hematopoietic-Granulocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TPSAB1 ADAM12 TPSB2 GNPTAB

1.05e-051923247af799b624167d1751c83e26b056be3692136c39
ToppCellcellseq-Immune-Hematopoietic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TPSAB1 ADAM12 TPSB2 GNPTAB

1.05e-05192324a081624e81e6fca8bb8da58fc2809af451c7315c
ToppCellcellseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TPSAB1 ADAM12 TPSB2 GNPTAB

1.05e-05192324b29d6b4bed4d55060586276973732461538752df
ToppCellCOVID-19_Moderate-B_naive|World / disease group, cell group and cell class

ZCCHC7 PIK3C2B NIBAN3 MACROD2

1.10e-051943241f81d618799e482a36dce528bba70f52cc69a901
ToppCellmedial-2-Hematologic-Basophil/Mast_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.10e-0519432454d33508ce35b3d214214e4efbbb62f358667105
ToppCellmedial-Hematologic-Basophil/Mast_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.10e-05194324a89a03d4adebb9f644c27e199bff267180d8ef18
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TPSAB1 ADAM12 TPSB2 GNPTAB

1.10e-05194324aca009b9f1f320c0a65ea16df6595d7ede0b1fda
ToppCellILEUM-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ZCCHC7 NIBAN3 CEMIP2 MACROD2

1.10e-05194324a89e67a40382600739be92e395bf47dd44aa4122
ToppCell3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPSAB1 ADAM12 TPSB2 GNPTAB

1.10e-051943249d7f232ef5f27c28f325edfa6614f479013acbba
ToppCellmedial-Hematologic-Basophil/Mast_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.10e-05194324ccfc142fe10b4ba16f3036f3f352983ee3e9c8ec
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPSAB1 TPSB2 ACP5 GNPTAB

1.12e-051953241f07502597e9476345b07f9f25aeeb6c1de13013
ToppCelldistal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.12e-051953244f83449fce3717518e2acbba1a4b3bea765c0bdb
ToppCellmild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2)

ZCCHC7 PIK3C2B NIBAN3 MACROD2

1.12e-05195324e763d9a431052c03cc6d514f2736506c6667e2be
ToppCellMild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ZCCHC7 TTC28 NIBAN3 MACROD2

1.12e-051953240a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

TMTC2 ZCCHC7 TTC28 MACROD2

1.14e-05196324ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCelldistal-2-Hematologic-Basophil/Mast_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.14e-05196324ad21706a281f0b105eb3979e3e47fe0cec6c527f
ToppCelldistal-Hematologic-Basophil/Mast_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

TPSAB1 ADAM12 TPSB2 GNPTAB

1.14e-051963243df0f8fce94bd573f9f9dfeb06d5f68202627740
ToppCellSepsis-Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, condition lineage and cell class

ZCCHC7 NIBAN3 ACP5 MACROD2

1.21e-05199324e3edf3bcb381dbcf0092bdc2ee93ba852d32af3f
ToppCelldistal-Epithelial-Differentiating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PLA2G2F GALNT5 MUC2 PADI1

1.21e-05199324286d52f25120293620bdbfd62b832f08e118adf6
ToppCelldistal-Epithelial-Differentiating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PLA2G2F GALNT5 MUC2 PADI1

1.21e-05199324a1b87c74fe3106ff8bf1c6ff4048d0c3d3fee7ba
ToppCellControl-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class

ZCCHC7 NIBAN3 ACP5 MACROD2

1.21e-05199324ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95
ToppCellBronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TPSAB1 ADAM12 TPSB2 DYRK1B

1.21e-051993246e7f7214317f2af2ba8523df9896f54b7294d58a
ToppCellBronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TPSAB1 ADAM12 TPSB2 DYRK1B

1.21e-051993245f499595597c10857bba8272f62afe4d32d733ac
ToppCelldistal-1-Epithelial-Differentiating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PLA2G2F GALNT5 MUC2 PADI1

1.21e-05199324fe7d6f70fe337b91b0ad63ea33e5a714d2df87bd
ToppCellBronchial-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TPSAB1 ADAM12 TPSB2 GNPTAB

1.24e-0520032496540be0e906bbc626049a41978be3dc051d2024
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class

ZCCHC7 PIK3C2B NIBAN3 MACROD2

1.24e-05200324e6a43eff47195e1d39530ad49ad908fc06a8b038
ToppCellBronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TPSAB1 ADAM12 TPSB2 GNPTAB

1.24e-0520032441d7736427494cb30a2f23722ea2b86ff308cfd8
ToppCellmild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZCCHC7 PIK3C2B NIBAN3 MACROD2

1.24e-05200324222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCellBiopsy_Control_(H.)-Immune-Mast_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

TPSAB1 ADAM12 TPSB2 GNPTAB

1.24e-0520032464bf125e0e5652a5a638a6bb32eb109cb0d5e232
ToppCellBiopsy_IPF-Immune-Mast_cells|Biopsy_IPF / Sample group, Lineage and Cell type

TPSAB1 ADAM12 TPSB2 GNPTAB

1.24e-0520032444d07a3fa768ccdcd2a0483a41483d5c11c9111e
ToppCellmild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZCCHC7 PIK3C2B NIBAN3 MACROD2

1.24e-05200324d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DCAF17 NIBAN3 DENND3

3.21e-0586323d20ec61a572b11641647358a546334b217c694f3
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

TPSAB1 MUC2 TPSB2

6.88e-051113231847dde68d349114286bc3317be6339666df4aa2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TPSAB1 TPSB2 PADI1

9.11e-05122323032b5da8befcb1a159245f8d0c67f91795883ee0
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-basophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TPSAB1 ADAM12 TPSB2

9.79e-05125323dec39707624529689f68dd46f910a71db5e91ab2
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLA2G2F NIBAN3 MACROD2

1.07e-0412932358790c6eaa597b8e8209a0fbc970e9cffa10bca5
ToppCellSevere-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass

TPSAB1 ADAM12 TPSB2

1.52e-04145323ce307d45425a5191882078f049f85477eec40b69
ToppCellSevere-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass

TPSAB1 ADAM12 TPSB2

1.52e-04145323e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127
ToppCellChildren_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 TPSB2

1.55e-04146323f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCell10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue

LRP2 ADAM12 CFHR4

1.55e-041463231cb2e157222631e8915d89b255a843d16d7d99cc
ToppCellMild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ZCCHC7 NIBAN3 CEMIP2

1.61e-04148323dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZCCHC7 NIBAN3 MACROD2

1.68e-04150323d9931507257c64ead4a53786e6822f51962c6015
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ZCCHC7 PIK3C2B NIBAN3

1.71e-041513230f8f07e44c6edaf09574930b416fdce14d67095a
ToppCell368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells)

TPSAB1 ADAM12 TPSB2

1.74e-04152323faf30245a1690aaa27c7be0832797c340e4af4d7
ToppCell368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells)

TPSAB1 ADAM12 TPSB2

1.74e-04152323519c9ed05fdaf420e42147ffae1dc05a7f86fdd4
ToppCellHealthy-B_cell|Healthy / disease group, cell group and cell class

ZCCHC7 NIBAN3 MACROD2

1.78e-041533237f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7
ToppCellAdult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 TPSB2

1.85e-041553237c9de0591d1bf756b8e268b278bbe10bd5415dcd
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TPSAB1 ADAM12 TPSB2

1.85e-04155323231fbbbd6e6f9c86be7a15a9ec0804e6b9ab3b5f
ToppCellCOVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations)

TPSAB1 ADAM12 TPSB2

1.88e-04156323159504d43421ee83b9ab484816333ae549c9c2fd
ToppCellCOVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations)

TPSAB1 ADAM12 TPSB2

1.88e-04156323bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCellAdult-Immune-mast_cell-D231|Adult / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 TPSB2

1.92e-041573234c63bb91f8708644e6ce2500072a4eeb8e1079dd
ToppCellChildren_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 TPSB2

1.92e-04157323ec185dbeabb67fd9ca85f71cab88463b60f9b1c1
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TPSAB1 TPSB2 GNPTAB

1.92e-041573233aa12913410925d577205cb6f1f5ae6bea20d93f
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

TPSAB1 ADAM11 ANGPTL2

1.99e-041593233f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells)

TPSAB1 ADAM12 TPSB2

2.03e-04160323a2f09b5955602819c8978f4372130c8ef915cd07
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZCCHC7 NIBAN3 MACROD2

2.03e-041603238396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPSAB1 TPSB2 PADI1

2.03e-04160323ca212634cf1875238071d1800ecdf34979a553fb
ToppCell343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells)

TPSAB1 ADAM12 TPSB2

2.03e-04160323133ecae0a894d9a0d49d58859623359096b6f030
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPSAB1 TPSB2 PADI1

2.03e-041603235d22c86deead516444349d495998e04586be4396
ToppCellAdult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor

TPSAB1 ADAM12 TPSB2

2.07e-0416132344f5c0256b3ce264a6c7b62740f32dcd45ee052d
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP2 TPSAB1 TPSB2

2.07e-041613231f4614ae15bd2fc08e555cea4d0152c4a940d048
Drugthymidine glycol monophosphate

TPSAB1 TPSB2

5.74e-063322CID000165415
DrugBrunfelsamidine

TPSAB1 TPSB2

1.15e-054322CID005281683
DruguPA inhibitor

LRP2 TPSAB1 TPSB2

1.22e-0532323CID000001746
DrugGPGR

TPSAB1 PBRM1 TPSB2

2.06e-0538323CID000485268
DrugAttpsa

TPSAB1 TPSB2

2.86e-056322CID005487511
Drugioxaglate

TPSAB1 TPSB2

4.00e-057322CID000003742
DrugTelebrix

TPSAB1 TPSB2

4.00e-057322CID000034536
Drugdaphnodorin C

TPSAB1 TPSB2

6.85e-059322CID000072428
Drug1c5s

TPSAB1 TPSB2

8.55e-0510322CID000444753
DrugAC1NUP69

TPSAB1 TPSB2

8.55e-0510322CID005487154
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A

ANGPTL2 CEMIP2 PADI1 GNPTAB

1.02e-041753242485_UP
DrugZ-ala-ala-lys-mna

TPSAB1 TPSB2

1.04e-0411322CID005486901
Drugpimaradiene

TPSAB1 TPSB2

1.04e-0411322CID000440909
Drugdaphnodorin A

TPSAB1 TPSB2

1.04e-0411322CID000072426
DrugAC1NSU64

TPSAB1 TPSB2

1.04e-0411322CID005316303
Drugmethylhistamine

TPSAB1 TPSB2

1.04e-0411322CID000000912
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

SEMA3A TTC28 ADAM12 PIK3C2B

1.07e-041773244652_DN
Drugbis(5-amidino-2-benzimidazolyl)methane

TPSAB1 TPSB2

1.25e-0412322CID000002386
DrugNSC-648146

TPSAB1 TPSB2

1.25e-0412322CID000372649
Drug4-amidinophenylpyruvic acid

TPSAB1 TPSB2

1.25e-0412322CID000151496
DrugElocom

TPSAB1 TPSB2

1.25e-0412322CID000123620
Drugnaphthol AS-D chloroacetate

TPSAB1 TPSB2 ACP5

1.35e-0471323CID000160247
DrugBeta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A

ADAM11 ANGPTL2 GNPTAB DYRK1B

1.47e-041923243807_UP
DrugZ-ARR-AFC

TPSAB1 TPSB2

1.48e-0413322CID000125067
DrugNk3201

TPSAB1 TPSB2

1.48e-0413322CID000213050
DrugPrednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A

DCAF17 SEMA3A TTC28 CEMIP2

1.49e-041933245119_DN
DrugCefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A

LRP2 CEMIP2 PADI1 GNPTAB

1.55e-041953246159_UP
DrugKaempferol [520-18-3]; Up 200; 14uM; HL60; HT_HG-U133A

TTC28 CEMIP2 PADI1 GNPTAB

1.55e-041953246157_UP
Drug2-propylpentanoic acid; Up 200; 500uM; MCF7; HG-U133A

RWDD2A MUC2 DENND3 CEMIP2

1.59e-04196324347_UP
DrugDO 897/99; Up 200; 8.2uM; HL60; HG-U133A

PIK3C2B MUC2 SUPT6H ACP5

1.59e-041963241728_UP
DrugIndapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

LRP2 ANGPTL2 ADAM12 GNPTAB

1.62e-041973243859_UP
DrugVigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A

TTC28 PIK3C2B SUPT6H GNPTAB

1.62e-041973245415_DN
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A

MICAL1 PIK3C2B PADI1 GNPTAB

1.62e-041973242887_DN
DrugCotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A

LRP2 MEGF8 ADAM12 MUC2

1.62e-041973245611_UP
Drugraloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A

SEMA3A DELE1 DENND3 PADI1

1.65e-04198324202_DN
DrugAC1L8TZY

TPSAB1 TPSB2 ACP5

1.65e-0476323CID000408095
DrugABPH

TPSAB1 TPSB2

1.72e-0414322CID000092377
DrugAC1L9K4M

TPSAB1 TPSB2

1.99e-0415322CID000446820
DrugFdTTP

TPSAB1 TPSB2

1.99e-0415322CID000162005
Drug5 alpha-androstan-3-one

TPSAB1 TPSB2

2.27e-0416322CID000102028
Drugthymidine glycol

TPSAB1 TPSB2

2.27e-0416322CID003035041
Drug(E)-4-aminohex-4-enoic acid

TPSAB1 TPSB2

2.27e-0416322CID005288385
Drugmethylimidazoleacetic acid

TPSAB1 TPSB2

2.57e-0417322CID000075810
DrugH 17

TPSAB1 TPSB2

2.57e-0417322CID000476867
DrugLMWH

SEMA3A LRP2 TPSAB1 ADAM12 TPSB2 CFHR4

2.83e-04663326CID000000772
Drug2-azetidinone

TPSAB1 TPSB2

2.89e-0418322CID000136721
DrugNSC49103

TPSAB1 TPSB2

3.58e-0420322CID000005251
DrugA80a

TPSAB1 TPSB2

3.58e-0420322CID005487000
Druglead phosphate

PBRM1 ACP5

3.58e-0420322CID000024009
Diseasetartrate-resistant acid phosphatase type 5 measurement

ACP5 GNPTAB

6.83e-064322EFO_0020763
Diseasetryptase beta-2 measurement

TPSAB1 TPSB2

4.08e-059322EFO_0008306
Diseasemood disorder

PBRM1 MACROD2

8.82e-0513322EFO_0004247
Diseaseurticaria

TPSAB1 TPSB2

2.14e-0420322EFO_0005531
Diseasecoronary aneurysm

TMTC2 MACROD2

6.63e-0435322EFO_1000881
Diseasebasophil measurement

TPSAB1 TPSB2

1.94e-0360322EFO_0803539
Diseasebiological sex

ADAM11 TTC28 MACROD2

1.96e-03230323PATO_0000047
Diseaseneuroimaging measurement, brain volume measurement

SEMA3A PBRM1 MACROD2

3.63e-03286323EFO_0004346, EFO_0006930
Diseasebeverage consumption measurement

DELE1 MACROD2

3.67e-0383322EFO_0010088

Protein segments in the cluster

PeptideGeneStartEntry
AEGKAHLDFHCNEYG

DCAF17

446

Q5H9S7
NLHKLDGYYCDHEQG

ADAM11

526

O75078
VYLHDGHSCQDVDGY

ADAM12

506

O43184
HQELQGYYDNADKLH

AMOTL1

456

Q8IY63
RDHDVYTGNCAHYQK

ANGPTL2

421

Q9UKU9
LHDEYCFYNGKTHRE

DENND3

86

A2RUS2
KVLNHGYDDDNHDYI

DYRK1B

86

Q9Y463
DDYLSYHELQGEIHC

PADI1

631

Q9ULC6
FSHKEEYENGGHCLG

NIBAN3

131

Q86XR2
GEPGCHYFEQLHYND

PBRM1

1141

Q86U86
DAGDCGQDHFHELYK

GNPTAB

531

Q3T906
GKHYYEVSCHDQGLC

DDX1

131

Q92499
GDCYYVLAKGDHNDS

MUC2

411

Q02817
NVHTHYQEEKCYEDG

MEGF8

466

Q7Z7M0
YEQHPGDGHFYCLQH

MICAL1

736

Q8TDZ2
YEYKCGNGHCIPHDN

LRP2

3931

P98164
YQELFDQGCHPYVDH

PLA2G2F

71

Q9BZM2
QNKHALGSHEYIQYC

PIK3C2B

436

O00750
YKELFYGHGDHLIDQ

GALNT5

756

Q7Z7M9
FHLCGDVDYKGGYRH

CEMIP2

551

Q9UHN6
CEFPEIQHGHLYYEN

CFHR4

271

Q92496
YSKAQYNAGLCHEHG

DELE1

276

Q14154
GHINGSHKEDLANCY

MACROD2

151

A1Z1Q3
HICDAKYHLGAYTGD

TPSAB1

186

Q15661
HICDAKYHLGAYTGD

TPSB2

186

P20231
QKDSGNYLCHAVEHG

SEMA3A

641

Q14563
LLEAHGDYGLRNDYH

RWDD2A

246

Q9UIY3
LLNHKYYQDCSGGDR

SUPT6H

1426

Q7KZ85
NLGKLYHEQGHYEEA

TMTC2

611

Q8N394
YGVTAYLCGHDHNLQ

ACP5

231

P13686
YLCGHDHNLQYLQDE

ACP5

236

P13686
EGEGKVCHNLGYAHY

TTC28

631

Q96AY4
YHCAQKGHYGHECPE

ZCCHC7

351

Q8N3Z6